BMC Digital Health is calling for submissions to our Collection, Digital health in rare diseases. This collection aims to explore the integration of digital health to the treatment and management of rare diseases, their early and accurate diagnosis, novel therapeutic intervention, patient empowerment, and the ethical implications of deploying digital health technologies in the context of rare diseases, considering issues such as data privacy, equity, and accessibility.
The implementation of digital technologies in the field of rare diseases represents a frontier where innovation can make an impact on patient outcomes and our understanding of these conditions. By leveraging digital health technologies, we can decipher patterns, identify biomarkers, and enhance diagnostic precision, ultimately leading to more effective treatments. Collaborative efforts have unveiled new genetic mutations, refined disease classifications, and uncovered shared pathways across seemingly distinct rare diseases. Looking ahead, the continued exploration of digital health in the rare disease landscape could potentially uncover novel therapeutic targets and accelerate the translation of research findings into tangible benefits for patients.
We invite contributions that examine a wide range of topics relating to the impact of digital health on rare diseases, including but not limited to:
- Rare disease registries and digital health integration
- Artificial intelligence for early diagnosis of rare diseases
- Wearable technology in remote monitoring
- Telemedicine and teleconsultation for improved patient access
- Digital therapeutics for disease management
- Mobile health apps in empowering patients with rare diseases
- Health informatics and big data analytics
- Telehealth services and E-health solutions for patient-centric care
This collection supports and amplifies research related to SDG 3: Good Health & Well-Being
Image credit: © Chinnapong / Stock.adobe.com